Cardiovascular Research

Transplanting old organs promotes senescence in young recipients.

Authors: Jasper Iske|||Maximilian J Roesel|||Friederike Martin|||Andreas Schroeter|||Tomohisa Matsunaga|||Ryoichi Maenosono|||Utkarsh Tripathi|||Yao Xiao|||Yeqi Nian|||Barbara J Caldarone|||Florian W R Vondran|||Peter T Sage|||Haruhito Azuma|||Reza Abdi|||Abdallah Elkhal|||Tamar Pirtskhalava|||Tamara Tchkonia|||James L Kirkland|||Hao Zhou|||Stefan G Tullius

Affiliations: + Expand

Abstract

In clinical organ transplantation, donor and recipient ages may differ substantially. Old donor organs accumulate senescent cells that have the capacity to induce senescence in naïve cells. We hypothesized that the engraftment of old organs may induce senescence in younger recipients, promoting age-related pathologies. When performing isogeneic cardiac transplants between age-mismatched C57BL/6 old donor (18 months) mice and young and middle-aged C57BL/6 (3- or 12- month-old) recipients , we observed augmented frequencies of senescent cells in draining lymph nodes, adipose tissue, livers, and hindlimb muscles 30 days after transplantation. These observations went along with compromised physical performance and impaired spatial learning and memory abilities. Systemic levels of the senescence-associated secretory phenotype factors, including mitochondrial DNA (mt-DNA), were elevated in recipients. Of mechanistic relevance, injections of mt-DNA phenocopied effects of age-mismatched organ transplantation on accelerating aging. Single treatment of old donor animals with senolytics prior to transplantation attenuated mt-DNA release and improved physical capacities in young recipients. Collectively, we show that transplanting older organs induces senescence in transplant recipients, resulting in compromised physical and cognitive capacities. Depleting senescent cells with senolytics, in turn, represents a promising approach to improve outcomes of older organs.

---

Chemical List

Senotherapeutics|||DNA

---

Reference List

Daley MJ, Spinks WL. Exercise, mobility and aging. Sports Med 2000;29(1):1–12.|||Groessl EJ, Kaplan RM, Rejeski WJ, Katula JA, Glynn NW, King AC et al. Physical Activity and Performance Impact Long-term Quality of Life in Older Adults at Risk for Major Mobility Disability. Am J Prev Med 2019;56(1):141–146.|||Clark R, Freedberg M, Hazeltine E, Voss MW. Are There Age-Related Differences in the Ability to Learn Configural Responses? PLoS One 2015;10(8):e0137260.|||Foster TC, Defazio RA, Bizon JL. Characterizing cognitive aging of spatial and contextual memory in animal models. Front Aging Neurosci 2012;4:12.|||Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 2019;15(10):565–581.|||Tullius SG, Milford E. Kidney allocation and the aging immune response. N Engl J Med 2011;364(14):1369–1370.|||Saidi RF, Hejazii Kenari SK. Challenges of organ shortage for transplantation: solutions and opportunities. Int J Organ Transplant Med 2014;5(3):87–96.|||Hart A, Smith JM, Skeans MA, Gustafson SK, Stewart DE, Cherikh WS et al. OPTN/SRTR 2015 Annual Data Report: Kidney. Am J Transplant 2017;17 Suppl 1:21–116.|||Iske J, Seyda M, Heinbokel T, Maenosono R, Minami K, Nian Y et al. Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation. Nat Commun 2020;11(1):4289.|||Acosta JC, O’Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 2008;133(6):1006–1018.|||Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008;133(6):1019–1031.|||Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 2008;132(3):363–374.|||Herranz N, Gil J. Mechanisms and functions of cellular senescence. J Clin Invest 2018;128(4):1238–1246.|||Xu M, Pirtskhalava T, Farr JN, Weigand BM, Palmer AK, Weivoda MM et al. Senolytics improve physical function and increase lifespan in old age. Nat Med 2018;24(8):1246–1256.|||Xu M, Bradley EW, Weivoda MM, Hwang SM, Pirtskhalava T, Decklever T et al. Transplanted Senescent Cells Induce an Osteoarthritis-Like Condition in Mice. J Gerontol A Biol Sci Med Sci 2017;72(6):780–785.|||Jeon OH, Mehdipour M, Gil TH, Kang M, Aguirre NW, Robinson ZR et al. Systemic induction of senescence in young mice after single heterochronic blood exchange. Nat Metab 2022;4(8):995–1006.|||Monaco AP. Chimerism in organ transplantation: conflicting experiments and clinical observations. Transplantation 2003;75(9 Suppl):13s–16s.|||Richter N, Raddatz G, Graeter T, Schäfers HJ, Schlitt HJ. Allogeneic lymphocyte chimerism after clinical lung transplantation. Transpl Immunol 1995;3(1):74–80.|||Schlitt HJ, Kanehiro H, Raddatz G, Steinhoff G, Richter N, Nashan B et al. Persistence of donor lymphocytes in liver allograft recipients. Transplantation 1993;56(4):1001–1007.|||Iske J, Matsunaga T, Zhou H, Tullius SG. Donor and Recipient Age-Mismatches: The Potential of Transferring Senescence. Front Immunol 2021;12:671479.|||Mina AI, LeClair RA, LeClair KB, Cohen DE, Lantier L, Banks AS. CalR: A Web-Based Analysis Tool for Indirect Calorimetry Experiments. Cell Metab 2018;28(4):656–666 e651.|||Hernandez-Segura A, Nehme J, Demaria M. Hallmarks of Cellular Senescence. Trends Cell Biol 2018;28(6):436–453.|||Prata L, Ovsyannikova IG, Tchkonia T, Kirkland JL. Senescent cell clearance by the immune system: Emerging therapeutic opportunities. Semin Immunol 2018;40:101275.|||Karin O, Agrawal A, Porat Z, Krizhanovsky V, Alon U. Senescent cell turnover slows with age providing an explanation for the Gompertz law. Nat Commun 2019;10(1):5495.|||Shoji H, Takao K, Hattori S, Miyakawa T. Age-related changes in behavior in C57BL/6J mice from young adulthood to middle age. Mol Brain 2016;9:11.|||Ogrodnik M, Zhu Y, Langhi LGP, Tchkonia T, Kruger P, Fielder E et al. Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis. Cell Metab 2019;29(5):1061–1077 e1068.|||Ogrodnik M, Evans SA, Fielder E, Victorelli S, Kruger P, Salmonowicz H et al. Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice. Aging Cell 2021;20(2):e13296.|||Kraeuter AK, Guest PC, Sarnyai Z. The Open Field Test for Measuring Locomotor Activity and Anxiety-Like Behavior. Methods Mol Biol 2019;1916:99–103.|||Meeker HC, Chadman KK, Heaney AT, Carp RI. Assessment of social interaction and anxiety-like behavior in senescence-accelerated-prone and -resistant mice. Physiol Behav 2013;118:97–102.|||Mintzer JE, Brawman-Mintzer O. Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach. J Clin Psychiatry 1996;57 Suppl 7:55–63; discussion 73–55.|||Prieur EAK, Jadavji NM. Assessing Spatial Working Memory Using the Spontaneous Alternation Y-maze Test in Aged Male Mice. Bio Protoc 2019;9(3):e3162.|||Davis KE, Burnett K, Gigg J. Water and T-maze protocols are equally efficient methods to assess spatial memory in 3xTg Alzheimer’s disease mice. Behav Brain Res 2017;331:54–66.|||de Fiebre NC, Sumien N, Forster MJ, de Fiebre CM. Spatial learning and psychomotor performance of C57BL/6 mice: age sensitivity and reliability of individual differences. Age (Dordr) 2006;28(3):235–253.|||Xu M, Palmer AK, Ding H, Weivoda MM, Pirtskhalava T, White TA et al. Targeting senescent cells enhances adipogenesis and metabolic function in old age. Elife 2015;4:e12997.|||Ostler JE, Maurya SK, Dials J, Roof SR, Devor ST, Ziolo MT et al. Effects of insulin resistance on skeletal muscle growth and exercise capacity in type 2 diabetic mouse models. Am J Physiol Endocrinol Metab 2014;306(6):E592–605.|||Dookun E, Walaszczyk A, Redgrave R, Palmowski P, Tual-Chalot S, Suwana A et al. Clearance of senescent cells during cardiac ischemia-reperfusion injury improves recovery. Aging Cell 2020;19(10):e13249.|||Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011;479(7372):232–236.|||Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz DP, Goldstein J et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008;6(12):2853–2868.|||Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol 2013;15(8):978–990.|||Zhu M, Min S, Mao X, Zhou Y, Zhang Y, Li W et al. Interleukin-13 promotes cellular senescence through inducing mitochondrial dysfunction in IgG4-related sialadenitis. Int J Oral Sci 2022;14(1):29.|||Anderson ML, Kinnison J, Pessoa L. Describing functional diversity of brain regions and brain networks. Neuroimage 2013;73:50–58.|||Al-Naggar IMA, Kuchel GA, Xu M. Senolytics: targeting senescent cells for age-associated diseases. Curr Mol Biol Rep 2020;6(4):161–172.|||Lee JR, Park BW, Park JH, Lim S, Kwon SP, Hwang JW et al. Local delivery of a senolytic drug in ischemia and reperfusion-injured heart attenuates cardiac remodeling and restores impaired cardiac function. Acta Biomater 2021;135:520–533.|||Graber TG, Maroto R, Fry CS, Brightwell CR, Rasmussen BB. Measuring Exercise Capacity and Physical Function in Adult and Older Mice. J Gerontol A Biol Sci Med Sci 2021;76(5):819–824.|||Shoji H, Miyakawa T. Age-related behavioral changes from young to old age in male mice of a C57BL/6J strain maintained under a genetic stability program. Neuropsychopharmacol Rep 2019;39(2):100–118.|||Bromley-Brits K, Deng Y, Song W. Morris water maze test for learning and memory deficits in Alzheimer’s disease model mice. J Vis Exp 2011(53).|||Maggio M, Guralnik JM, Longo DL, Ferrucci L. Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci 2006;61(6):575–584.|||Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 2002;59(3):371–378.|||Takahashi S, Fukushima H, Yu Z, Tomita H, Kida S. Tumor necrosis factor α negatively regulates the retrieval and reconsolidation of hippocampus-dependent memory. Brain Behav Immun 2021;94:79–88.|||Mygind L, Bergh MS, Tejsi V, Vaitheeswaran R, Lambertsen KL, Finsen B et al. Tumor Necrosis Factor (TNF) Is Required for Spatial Learning and Memory in Male Mice under Physiological, but Not Immune-Challenged Conditions. Cells 2021;10(3).|||Lin YF, Wang LY, Chen CS, Li CC, Hsiao YH. Cellular senescence as a driver of cognitive decline triggered by chronic unpredictable stress. Neurobiol Stress 2021;15:100341.|||Muñoz-Espín D, Serrano M. Cellular senescence: from physiology to pathology. Nat Rev Mol Cell Biol 2014;15(7):482–496.|||Song P, An J, Zou MH. Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases. Cells 2020;9(3).|||Yousefzadeh MJ, Flores RR, Zhu Y, Schmiechen ZC, Brooks RW, Trussoni CE et al. An aged immune system drives senescence and ageing of solid organs. Nature 2021;594(7861):100–105.|||Zhang P, Kishimoto Y, Grammatikakis I, Gottimukkala K, Cutler RG, Zhang S et al. Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer’s disease model. Nat Neurosci 2019;22(5):719–728.|||Justice JN, Nambiar AM, Tchkonia T, LeBrasseur NK, Pascual R, Hashmi SK et al. Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. EBioMedicine 2019;40:554–563.|||Zhao H, Alam A, Soo AP, George AJT, Ma D. Ischemia-Reperfusion Injury Reduces Long Term Renal Graft Survival: Mechanism and Beyond. EBioMedicine 2018;28:31–42.|||Salvadori M, Rosso G, Bertoni E. Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment. World J Transplant 2015;5(2):52–67.|||Koppelstaetter C, Kern G, Leierer G, Mair SM, Mayer G, Leierer J. Effect of cyclosporine, tacrolimus and sirolimus on cellular senescence in renal epithelial cells. Toxicol In Vitro 2018;48:86–92.|||Kim YC, Guan KL. mTOR: a pharmacologic target for autophagy regulation. J Clin Invest 2015;125(1):25–32.|||Singh AK, Singh S, Garg G, Rizvi SI. Rapamycin mitigates erythrocyte membrane transport functions and oxidative stress during aging in rats. Arch Physiol Biochem 2018;124(1):45–53.|||Sakaki M, Ebihara Y, Okamura K, Nakabayashi K, Igarashi A, Matsumoto K et al. Potential roles of DNA methylation in the initiation and establishment of replicative senescence revealed by array-based methylome and transcriptome analyses. PLOS ONE 2017;12(2):e0171431.|||Wang Y, Gao J, Wu F, Lai C, Li Y, Zhang G et al. Biological and epigenetic alterations of mitochondria involved in cellular replicative and hydrogen peroxide-induced premature senescence of human embryonic lung fibroblasts. Ecotoxicology and Environmental Safety 2021;216:112204.|||Yu D, Du Z, Pian L, Li T, Wen X, Li W et al. Mitochondrial DNA Hypomethylation Is a Biomarker Associated with Induced Senescence in Human Fetal Heart Mesenchymal Stem Cells. Stem Cells Int 2017;2017:1764549.|||Di Giorgio E, Paluvai H, Dalla E, Ranzino L, Renzini A, Moresi V et al. HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancers. Genome Biol 2021;22(1):129.